Tradestie Institutional Equity Comparison Engine
MBRX vs CNSY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBRX Overall Edge
MBRX Captures Institutional Edge (3โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Moleculin Biotech, Inc. (MBRX) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, MBRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CNSY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MBRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNSY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MBRX
MBRX N/M vs CNSY N/M Fwd P/E
Growth & Margin Winner
MBRX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
MBRX
1Y +1547.9% vs -79.5% ยท 52W Pos 73% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBRX
NASDAQ
Moleculin Biotech, Inc.
Pharmaceutical Preparations
$7.48
-4.96% 1D
Market Cap
$7.9M
1M Return
+2567.62%
1Y Return
+1547.94%
Forward P/E
N/M
Unified AI Score
35.5 / 100
SELL
Tech 24.0
Fund 33.0
Flow 50.0
Mom 40.0
CNSY
US Equity
CNSY
Institutional Equity
$0.72
-24.24% 1D
Market Cap
N/A
1M Return
-57.65%
1Y Return
-79.55%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MBRX +1547.94%
CNSY -79.55%
Spread: +1739.55 pp (MBRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MBRX TTM Op. Margin: 0.0%
CNSY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBRX vs CNSY. Trailing 12-month operating profitability (MBRX 0.0% vs CNSY N/A) and valuation multiples (MBRX N/M vs CNSY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBRX | CNSY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.9M | N/A | Larger Scale | MBRX |
| Trailing P/E Ratio Valuation | 0.0x | N/M | Lower Multiple | MBRX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | MBRX |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | MBRX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | MBRX |
| Return on Equity (ROE) Capital Efficiency | -1371.6% | N/A | Higher ROE | MBRX |
| 52-Week Range Position Momentum | 73% ($0โ$10) | 8% ($0โ$4) | Stronger Trend | MBRX |
| Beta / 30D Volatility Risk Regime | 4.61ฮฒ ยท 7732% Vol | 2.54ฮฒ ยท 228% Vol | Lower Realized Risk | CNSY |
| Unified Institutional Score Composite Signal | 35.5 / 100 (SELL) | 47.6 / 100 (HOLD) | Higher Composite | CNSY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MBRX vs CNSY Buy Guide
MBRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CNSY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MBRX nor CNSY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.